WaitesKBTalkingtonDF.Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
2.
RavinKARappaportLDZuckerbraunNSWadowskyRMWaldERMichaelsMM.Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Pediatrics. 2007;119:e1002-e1005.
3.
ZãoIRibeiroFRochaVNetoPMatiasCJesusG.Mycoplasma pneumoniae–associated mucositis: a recently described entity. Eur J Case Rep Intern Med. 2018;5:000977.
4.
CanavanTNMathesEFFriedenIShinkaiK.Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Steven-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72:239-245.
BirchJChamlinSDuerstRJacobsohnD.Mycoplasma pneumonia and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient. Pediatr Blood Cancer. 2008;50:1278-1279.
7.
ZipitisCSThalangeN.Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr. 2007;166:585-588.
8.
WieczorekMCzernikA.Paraneoplastic pemphigus: a short review. Clin Cosmet Investig Dermatol. 2016;9:291-295.
9.
SantosRSilvaMVieiraABritoC.Mycoplasma pneumoniae–induced rash and mucositis: a recently described entity. BMJ Case Rep. 2017;2017:bcr-2017-220768.
10.
SauteurPMMGoetschelPLautenschlagerS. Mycoplasma pneumoniae and mucositis—part of the Stevens-Johnson syndrome spectrum. J Dtsch Dermatol Ges. 2012;10:760-766.
